\n| Biological<\/td>\n | Advanced Age<\/td>\n | Accumulated genetic mutations<\/td>\n<\/tr>\n<\/table>\n By looking at these different factors, we can give you a more personal view of your health. Every person\u2019s experience with Myelodysplastic Syndrome<\/em> is unique. We\u2019re here to help you understand and support you through it.<\/p>\nRecognizing Common Symptoms and Clinical Presentations<\/h2>\nWhen the bone marrow can\u2019t make enough healthy blood cells, the body sends out warning signs. These signs come from the bone marrow not working right, leading to low blood cell counts. This is called cytopenia.<\/p>\n Spotting these signs early helps us work better with doctors. It\u2019s key to managing your health journey with confidence.<\/p>\n Anemia-Related Fatigue and Weakness<\/h3>\nAnemia happens when there aren\u2019t enough red blood cells to carry oxygen. This lack of oxygen causes persistent fatigue<\/em> that doesn\u2019t get better with rest. People often feel weak, short of breath, or lightheaded.<\/p>\nInfection Risks Due to Neutropenia<\/h3>\nNeutropenia means not enough neutrophils, which fight off germs. With fewer neutrophils, the body gets sick more easily. Watch for unexplained fevers, sore throats, or coughs.<\/p>\n Bleeding and Bruising from Thrombocytopenia<\/h3>\nThrombocytopenia means not enough platelets for blood to clot. This shows as easy bruising, small red spots, or bleeding that won\u2019t stop. If you see these signs, talk to your doctor right away.<\/p>\n \n- Unexplained or extreme exhaustion<\/li>\n
- Frequent or persistent infections<\/li>\n
- Easy bruising or unusual bleeding<\/li>\n
- Shortness of breath during daily tasks<\/li>\n<\/ul>\n
\n\n| Blood Cell Type<\/th>\n | Clinical Condition<\/th>\n | Common Symptom<\/th>\n<\/tr>\n | \n| Red Blood Cells<\/td>\n | Anemia<\/td>\n | Fatigue and Pallor<\/td>\n<\/tr>\n | \n| White Blood Cells<\/td>\n | Neutropenia<\/td>\n | Recurrent Infections<\/td>\n<\/tr>\n | \n| Platelets<\/td>\n | Thrombocytopenia<\/td>\n | Easy Bruising<\/td>\n<\/tr>\n<\/table>\n Knowing these symptoms of Myelodysplastic Syndrome helps you take charge of your care. Keep track of any changes to share with your doctor.<\/p>\n Diagnostic Procedures and Laboratory Testing<\/h2>\nDiagnosing Myelodysplastic Syndrome starts with checking your blood and bone marrow. We use a detailed method to find out what\u2019s wrong. This helps us make a care plan just for you.<\/p>\n Complete Blood Count and Peripheral Blood Smear<\/h3>\nWe first do a complete blood count (CBC). This test checks your red and white blood cells and platelets. Low numbers can hint at a problem.<\/p>\n Then, we do a peripheral blood smear. A pathologist looks at your blood under a microscope. They look for any odd cell shapes or sizes. Identifying abnormal cell morphology<\/em> is key to figuring out what\u2019s wrong.<\/p>\nBone Marrow Aspiration and Biopsy<\/h3>\nIf blood tests hint at Myelodysplastic Syndrome, we need to check the bone marrow. A bone marrow aspiration and biopsy give us the samples we need. We take both liquid marrow and a bone tissue sample.<\/p>\n These samples help us see how many immature cells are there. By looking at the bone marrow, we can confirm the diagnosis. This step is essential for understanding the severity<\/em> of the disease.<\/p>\nCytogenetic Analysis and Molecular Profiling<\/h3>\nModern tests let us study your cells\u2019 genes. Cytogenetic analysis finds chromosomal problems linked to Myelodysplastic Syndrome. This helps us know what type of disease you have and how it might progress.<\/p>\n Molecular profiling also looks for specific genetic changes. This advanced test helps us find the best treatments for you. By using these genetic insights, we aim for a more precise and personalized approach to your long-term care<\/em>.<\/p>\nClassification Systems for Myelodysplastic Syndrome<\/h2>\nDoctors use special systems to sort Myelodysplastic Syndrome into clear groups. This makes it easier to plan treatment for each patient. It helps predict how the disease will progress.<\/p>\n These systems make it easier to understand medical reports. They help patients talk more confidently about their health.<\/p>\n World Health Organization (WHO) Criteria<\/h3>\nThe WHO criteria are the main way to diagnose Myelodysplastic Syndrome worldwide. They look at how blood cells grow and for certain genetic signs.<\/p>\n Doctors use these criteria to guess how the disease might grow. This method is key in the U.S. and other countries.<\/p>\n International Consensus Classification (ICC)<\/h3>\nThe ICC is a newer way to define these blood disorders. It uses the latest science to improve diagnosis.<\/p>\n This system aims for more precise diagnosis. It helps doctors tailor treatments to each patient\u2019s needs.<\/p>\n Morphological Features and Blast Counts<\/h3>\nLooking at bone marrow under a microscope is key. Pathologists check for morphological features<\/em> that show abnormal cell growth.<\/p>\nThey also count blasts, which are young cells that haven\u2019t turned into blood cells yet. The number of blasts helps decide how serious the disease is:<\/p>\n \n- Low blast counts:<\/strong> Usually mean a less serious form of the disease.<\/li>\n
- Higher blast counts:<\/strong> Often point to a more aggressive disease that needs quick action.<\/li>\n
- Serial monitoring:<\/strong> Regular tests track changes in blast counts over time.<\/li>\n<\/ul>\n
Risk Stratification and Prognostic Scoring Systems<\/h2>\nPrognostic scoring systems are key for tracking Myelodysplastic Syndrome health. They help doctors create a care plan based on detailed data. By looking at certain biological markers, we can grasp a patient\u2019s unique situation.<\/p>\n Revised International Prognostic Scoring System (IPSS-R)<\/h3>\nThe IPSS-R is a major tool for Myelodysplastic Syndrome assessment. It checks for immature blood cells and chromosomal issues. This scoring helps us sort the disease into risk levels.<\/p>\n Molecular International Prognostic Scoring System (IPSS-M)<\/h3>\nThe IPSS-M uses genetic testing to better understand Myelodysplastic Syndrome. It looks at specific gene mutations. This gives us a clearer picture of the disease\u2019s future.<\/p>\n This approach is essential<\/em> for personalized medicine. It lets us tailor care based on a patient\u2019s genetic makeup. This makes our advice more accurate.<\/p>\nPredicting Disease Progression and Survival<\/h3>\nThese scoring systems are more than just numbers. They help predict disease progression. They guide us on whether to act aggressively or supportively. This is key for setting care goals.<\/p>\n We urge patients to talk about these scores with their doctors. Knowing their risk helps them make informed choices. Our aim is to support and inform patients every step of the way.<\/p>\n Current Standard Treatment Modalities<\/h2>\nWe focus on treating Myelodysplastic Syndrome<\/em> by keeping your blood counts stable. This improves your quality of life. The condition affects how your bone marrow makes blood cells. So, we aim to fix these issues.<\/p>\nHypomethylating Agents and Their Mechanism<\/h3>\nHypomethylating agents are often the first choice for many. These drugs target DNA markers that stop bone marrow cells from growing right.<\/p>\n By blocking these markers, the drugs help your marrow make healthy blood cells. This can cut down on the need for blood transfusions for those with Myelodysplastic Syndrome<\/em>.<\/p>\nImmunomodulatory Drugs<\/h3>\nImmunomodulatory drugs are key in our treatment plan. They help your immune system support healthy cell growth.<\/p>\n They work best for certain types of the disease, like those with a chromosome 5q deletion. These drugs adjust your immune response to help your body make more healthy blood cells.<\/p>\n Hematopoietic Stem Cell Transplantation<\/h3>\nFor some patients, a stem cell transplant is the only chance for a cure. This involves replacing your diseased bone marrow with healthy stem cells from a donor.<\/p>\n This is a big step, but it could lead to long-term remission. We check your health and disease risk to see if this is right for you.<\/p>\n \n\n| Treatment Type<\/th>\n | Primary Mechanism<\/th>\n | Main Goal<\/th>\n<\/tr>\n | \n| Hypomethylating Agents<\/td>\n | DNA regulation<\/td>\n | Improve blood counts<\/td>\n<\/tr>\n | \n| Immunomodulatory Drugs<\/td>\n | Immune system adjustment<\/td>\n | Support healthy cell growth<\/td>\n<\/tr>\n | \n| Stem Cell Transplant<\/td>\n | Marrow replacement<\/td>\n | Curative for Myelodysplastic Syndrome<\/td>\n<\/tr>\n<\/table>\nEmerging Therapies and Clinical Trials<\/h2>\nWe are entering a new era where precision medicine offers hope for those facing Myelodysplastic Syndrome. Researchers are working hard to find the unique biological drivers of this condition. They aim to create more effective interventions.<\/p>\n Targeted Therapies for Specific Mutations<\/h3>\nModern science lets us look closely at the genetic makeup of individual patients. By identifying specific mutations, doctors can now choose therapies that target the disease at its molecular source.<\/p>\n These targeted approaches aim to stop the growth of abnormal cells while sparing healthy tissue. This shift toward personalized care represents a significant leap forward in managing Myelodysplastic Syndrome effectively.<\/p>\n Novel Combination Regimens<\/h3>\nSome patients may not respond well to traditional treatment options. To address this, scientists are testing novel combination regimens. These pair different drugs to attack the disease from multiple angles.<\/p>\n These combinations often aim to overcome resistance mechanisms that the body might develop over time. By using drugs that work in harmony, we hope to achieve deeper and more durable responses for our patients.<\/p>\n The Importance of Participating in Clinical Research<\/h3>\nClinical trials are the backbone of medical progress. They provide a vital pathway for patients to access cutting-edge treatments that are not yet available to the general public.<\/p>\n Participating in research is a powerful<\/em> way for patients to contribute to the future of hematology. By joining a study, you help us gather the data needed to improve care for everyone living with Myelodysplastic Syndrome. Your involvement is a courageous step that helps turn scientific research into life-saving reality.<\/p>\nManaging Complications and Supportive Care<\/h2>\nWe focus on your comfort and stability with essential care in your Myelodysplastic Syndrome treatment. These steps help with the physical effects of the condition and keep you active. Our goal is to enhance your quality of life through these proactive measures.<\/p>\n Blood Transfusion Protocols and Iron Overload<\/h3>\nPatients with Myelodysplastic Syndrome often need regular blood transfusions to fight anemia. These transfusions help but can cause iron buildup over time. This buildup, or iron overload, needs regular checks through blood tests and organ function assessments.<\/p>\n When iron levels get too high, we might suggest iron chelation therapy. This treatment helps remove excess iron, protecting your heart and liver. Consistent monitoring<\/em> is vital to keep iron levels safe.<\/p>\nGrowth Factor Support and Erythropoiesis-Stimulating Agents<\/h3>\nWe use growth factors or erythropoiesis-stimulating agents to lower transfusion needs. These medications boost your bone marrow to make more healthy red blood cells. They work well for certain patients, helping to keep hemoglobin levels stable.<\/p>\n We check your blood counts to see if these agents are right for you. They help your body make more red blood cells naturally. This boosts your energy and reduces fatigue, key parts of our care plan.<\/p>\n Infection Prevention and Prophylactic Antibiotics<\/h3>\nMyelodysplastic Syndrome can weaken your immune system, making you more prone to infections. We guide you on hygiene and may prescribe prophylactic antibiotics. These prevent common infections before they start.<\/p>\n It\u2019s important to watch your health closely during treatment. Tell us right away if you have a fever or feel unwell. Your safety<\/em> is our top priority as we face these challenges together.<\/p>\nLifestyle Adjustments and Nutritional Considerations<\/h2>\nSmall, consistent changes in your daily habits can greatly improve your resilience during Myelodysplastic Syndrome<\/em> treatment. While medical treatments are key, your daily choices are also vital. Focus on nutrition, energy, and safety to actively participate in your care.<\/p>\nMaintaining a Balanced Diet During Treatment<\/h3>\nEating right gives your body the fuel it needs to repair cells and stay strong. Eat foods rich in lean proteins, whole grains, and colorful veggies to boost your immune system. Drinking plenty of water is also important, as it helps your kidneys work better with medications.<\/p>\n If you\u2019re feeling sick or taste changes, try eating smaller meals more often. Stay away from raw or undercooked foods to avoid getting sick, which is extra important when your blood counts are low.<\/p>\n Physical Activity and Energy Conservation Techniques<\/h3>\nFatigue is common with Myelodysplastic Syndrome<\/em>, but gentle exercise can help. Try walking or stretching when you\u2019re feeling your best. Always listen to your body and don\u2019t push too hard.<\/p>\nWorking smarter, not harder, is key to saving energy. Break big tasks into smaller steps and take breaks often. Use tools or ask for help with hard tasks to save energy for what\u2019s important to you.<\/p>\n Avoiding Environmental Hazards and Pathogens<\/h3>\nProtecting yourself from infections is a top priority when your immune system is weak. Washing your hands often is the best way to avoid germs in public. Also, avoid big crowds and people who are sick during flu season.<\/p>\n Keeping your living space clean is another simple way to stay safe. Regularly clean high-touch areas and make sure your home is free of mold or dust. These small steps help keep you safe while you focus on getting better.<\/p>\n \n\n| Focus Area<\/th>\n | Practical Strategy<\/th>\n | Expected Benefit<\/th>\n<\/tr>\n | \n| Nutrition<\/td>\n | Eat cooked, nutrient-dense meals<\/td>\n | Supports cellular repair<\/td>\n<\/tr>\n | \n| Activity<\/td>\n | Practice pacing and rest<\/td>\n | Reduces chronic fatigue<\/td>\n<\/tr>\n | \n| Safety<\/td>\n | Prioritize hand hygiene<\/td>\n | Lowers infection risk<\/td>\n<\/tr>\n | \n| Management<\/td>\n | Track Myelodysplastic Syndrome symptoms<\/td>\n | Improves clinical communication<\/td>\n<\/tr>\n<\/table>\nPsychological Impact and Coping Strategies<\/h2>\nMyelodysplastic Syndrome affects your mental health as much as your body. Living with a chronic illness brings emotional challenges that need patience and kindness towards yourself. Recognizing these feelings is the first step to building a strong mindset during treatment.<\/p>\n Addressing Anxiety and Depression in Chronic Illness<\/h3>\nIt\u2019s normal to feel anxious or sad when dealing with Myelodysplastic Syndrome. These feelings come from the uncertainty of blood counts or the fatigue of the disease. Prioritizing your mental health<\/em> shows strength, not weakness.<\/p>\nIf these feelings start to affect your daily life, it\u2019s important to talk to a healthcare professional. Many people find help in cognitive behavioral therapy or other specialized treatments. You don\u2019t have to face these emotions alone.<\/p>\n The Role of Support Groups and Counseling<\/h3>\nConnecting with others who understand you can be very validating. Support groups offer a safe place to share stories, exchange tips, and feel less alone. Whether in-person or online, these groups provide encouragement from peers.<\/p>\n Professional counseling offers a structured way to process your thoughts and find coping strategies. A therapist can help you deal with complex emotions and improve your quality of life. Here\u2019s a table showing different support options:<\/p>\n \n\n| Support Type<\/th>\n | Primary Benefit<\/th>\n | Best For<\/th>\n<\/tr>\n | \n| Peer Support Groups<\/td>\n | Shared experiences<\/td>\n | Reducing isolation<\/td>\n<\/tr>\n | \n| Individual Counseling<\/td>\n | Personalized strategies<\/td>\n | Managing deep anxiety<\/td>\n<\/tr>\n | \n| Caregiver Workshops<\/td>\n | Communication skills<\/td>\n | Family dynamics<\/td>\n<\/tr>\n<\/table>\nCommunicating Needs to Family and Caregivers<\/h3>\nTalking openly with your loved ones is key to a supportive home. It can be hard to ask for help when you\u2019re tired or overwhelmed. Be honest about your needs and how you\u2019re feeling.<\/p>\n \n- Schedule regular check-ins to discuss your feelings and needs.<\/li>\n
- Use \u201cI\u201d statements to explain your needs, like \u201cI\u2019m tired today and need some quiet.\u201d<\/li>\n
- Give caregivers clear tasks to make them feel involved and useful.<\/li>\n<\/ul>\n
By talking openly, you help your support system provide the best care. Remember, your family and friends want to help but may need guidance. Building this communication will strengthen your relationships and improve your ability to cope.<\/p>\n Navigating the Healthcare System in the United States<\/h2>\nDealing with Myelodysplastic Syndrome<\/em> in the U.S. healthcare system can be tough. We think a clear plan helps you focus on getting better. It makes dealing with paperwork easier.<\/p>\nFinding Specialized Hematology-Oncology Centers<\/h3>\nFor serious conditions, going to a specialized center is best. These places often do research and have the newest tools for Myelodysplastic Syndrome<\/em>.<\/p>\n\n- Look for National Cancer Institute (NCI)-designated cancer centers.<\/li>\n
- Check if the facility has a dedicated hematology department.<\/li>\n
- Inquire about the availability of multidisciplinary care teams.<\/li>\n<\/ul>\n
Understanding Insurance Coverage and Financial Assistance<\/h3>\nHandling Myelodysplastic Syndrome<\/em> costs needs a good plan. Know your insurance well, including what you pay upfront and the maximum you\u2019ll pay.<\/p>\nIf money is tight, there are ways to help. Look into:<\/p>\n \n- Patient assistance programs from drug companies.<\/li>\n
- Grants from non-profits for treatment costs.<\/li>\n
- Financial help from social workers at your treatment center.<\/li>\n<\/ul>\n
Coordinating Care Between Primary Physicians and Specialists<\/h3>\nGood communication between your primary doctor and hematologist is key. Your primary doctor helps with your overall health and non-blood-related needs.<\/p>\n Keep a single health file for all your doctors. This helps everyone stay on the same page. Here\u2019s how to improve teamwork:<\/p>\n \n- Ask your specialist to send visit summaries to your primary doctor.<\/li>\n
- Keep a list of all your medicines and supplements up to date.<\/li>\n
- Use patient portals to see lab results and appointments for Myelodysplastic Syndrome<\/em>.<\/li>\n<\/ul>\n
By working together, you support your health goals. Remember, you\u2019re a key part of your care team. Your opinions matter in every decision.<\/p>\n Long-Term Outlook and Quality of Life Considerations<\/h2>\nLiving with Myelodysplastic Syndrome means focusing on both health care and personal well-being. Modern medicine helps keep this condition stable. This lets patients keep up with daily life and enjoy meaningful activities.<\/p>\n Regular check-ups are key to good care. Working closely with your hematology team is important. They quickly address any changes in your blood counts or symptoms. This approach helps manage Myelodysplastic Syndrome and keeps it from affecting your lifestyle too much.<\/p>\n Improving your quality of life is a top priority. Making small changes to your diet, energy levels, and stress management can make a big difference. We suggest focusing on these self-care practices along with your medical treatments.<\/p>\n At Ac\u0131badem Healthcare Group, we\u2019re committed to helping you manage Myelodysplastic Syndrome. You\u2019re not facing this alone. We\u2019re here to support your health goals and help you live a full, active life at every stage of your care.<\/p>\n\nFAQ<\/h2>\n\n Q: What exactly is Myelodysplastic Syndrome and how does it affect the body?<\/h3>\n\n \n A: Myelodysplastic Syndrome is a group of bone marrow disorders. The bone marrow fails to produce enough healthy blood cells. This leads to low counts of red, white blood cells, and platelets.<\/p>\n This condition makes it hard for the body to carry oxygen, fight infections, and stop bleeding.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: Is Myelodysplastic Syndrome considered a form of cancer, and how does it differ from Acute Myeloid Leukemia (AML)?<\/h3>\n\n \n A: Yes, MDS is a type of blood cancer. It\u2019s different from AML based on the number of abnormal cells. If there are more than 20% blasts, it\u2019s AML.<\/p>\n Many patients with MDS live for years without turning into AML. Knowing this helps doctors decide the best treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What are the primary risk factors and causes associated with developing MDS?<\/h3>\n\n \n A: Many cases of MDS have no known cause. But, some risk factors include exposure to chemicals like benzene. People who had chemotherapy or radiation for other cancers are also at risk.<\/p>\n Age is another factor, as the chance of genetic mutations increases with time. Some people may be more likely to get MDS due to their genes.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What common symptoms should I look for if I suspect a blood-related issue?<\/h3>\n\n \n A: Look out for symptoms like fatigue, shortness of breath, and pale skin. These are signs of anemia.<\/p>\n Neutropenia can cause infections and fever. Thrombocytopenia leads to easy bruising and nosebleeds. These symptoms can be subtle, so regular blood tests are important.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What diagnostic tests are necessary to confirm a diagnosis of Myelodysplastic Syndrome?<\/h3>\n\n \n A: The journey starts with a Complete Blood Count (CBC) and a blood smear. A bone marrow aspiration and biopsy are needed for a definitive diagnosis.<\/p>\n These tests help identify the exact subtype of MDS. This information helps tailor a treatment plan for each patient.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: How do doctors use the WHO and ICC systems to classify MDS?<\/h3>\n\n \n A: Doctors use the WHO and ICC systems to categorize MDS. These systems look at the type of cell affected and the number of blasts.<\/p>\n At Ac\u0131badem, we use these classifications to understand the disease better. This helps predict how the disease might progress.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: How is my risk level determined using the IPSS-R or IPSS-M scoring systems?<\/h3>\n\n \n A: We use the IPSS-R and IPSS-M to assess the severity of MDS. These systems look at blood counts, blasts, and genetic mutations.<\/p>\n A higher score means a higher risk of the disease turning into AML. This helps us decide on the best treatment.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What are the current standard medical treatments for Myelodysplastic Syndrome?<\/h3>\n\n \n A: Treatment for MDS is highly individualized. We often use hypomethylating agents to help blood cells grow normally.<\/p>\n For some patients, immunomodulatory drugs like Lenalidomide are effective. For high-risk patients, a stem cell transplant is the only potentially curative option.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: Are there any new or emerging therapies available for MDS patients?<\/h3>\n\n \n A: Yes, there are new therapies for MDS. Targeted therapies address specific genetic mutations. New combination regimens are being tested in clinical trials.<\/p>\n We encourage patients to discuss clinical research opportunities. These trials offer access to cutting-edge medicine and help advance our understanding of MDS.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: How do you manage complications like iron overload and infections?<\/h3>\n\n \n A: Managing complications is a key part of our treatment. For iron overload, we may use iron chelation therapy. To prevent infections, we use growth factors and antibiotics.<\/p>\n Our goal is to improve quality of life by preventing complications before they become severe.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What lifestyle and nutritional changes can help support my health during treatment?<\/h3>\n\n \n A: Eating a balanced diet is important. It helps the body cope with treatment. We also advise on food safety and gentle exercise.<\/p>\n Conserving energy and resting when needed helps manage fatigue. This is common in patients with anemia.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: How can I manage the emotional and psychological impact of a chronic diagnosis?<\/h3>\n\n \n A: Living with MDS can be emotionally challenging. We recommend counseling and support groups. Open communication with family and caregivers is also vital.<\/p>\n At Ac\u0131badem Healthcare Group, we believe in supporting mental health. We provide resources to help patients cope emotionally.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: How should I navigate the healthcare system to ensure I get the best care for MDS?<\/h3>\n\n \n A: Navigating healthcare requires a proactive approach. Seek out specialized centers with experience in MDS. Coordinate care between your primary doctor and specialist.<\/p>\n Working with financial counselors can help understand insurance and find financial assistance. This allows you to focus on recovery.<\/p>\n<\/div>\n<\/div>\n<\/div>\n \n Q: What is the long-term outlook for someone diagnosed with MDS?<\/h3>\n\n \n A: The outlook varies based on the subtype and risk score. Modern treatments and supportive care help many patients manage symptoms and live well for years.<\/p>\n We focus on continuous monitoring and early intervention. Our goal is to support patients and provide the latest medical innovations.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"featured_media":96927,"template":"","categories":[1019,5],"class_list":["post-96423","idel_medical_unit","type-idel_medical_unit","status-publish","has-post-thumbnail","hentry","category-medical-units","category-treatment"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_medical_unit\/96423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_medical_unit"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_medical_unit"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/96927"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=96423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=96423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} | | | | |